MOC — Molecure SA Cashflow Statement
0.000.00%
Last trade - 00:00- PLN173.75m
- PLN162.79m
- PLN2.17m
Annual cashflow statement for Molecure SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 64.3 | -13.6 | -15.3 | -18.3 | -31.3 |
| Depreciation | |||||
| Non-Cash Items | -1.89 | 1.68 | -0.921 | -1.05 | 1.85 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.17 | -1.84 | 4.91 | 5.92 | -31.4 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 57.4 | -13.5 | -9.99 | -11.6 | -57 |
| Capital Expenditures | -2.09 | -2.45 | -3.32 | -0.362 | -0.655 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 10.7 | -16.4 | -30.5 | -44.4 | -22.9 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 8.58 | -18.8 | -33.8 | -44.8 | -23.6 |
| Financing Cash Flow Items | 21.9 | 8.29 | 6.99 | 5.05 | 5.14 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 20.4 | 13.9 | 7.38 | 54.7 | 34.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 86.5 | -18.5 | -36.4 | -1.62 | -45.8 |